Clinical Trial: The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population

U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07322653) titled 'The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population' on Dec. 22, 2025.

Brief Summary: Examining the effects of MediDrink Platinum+ containing novel protein blend SRP-01 alone or when combined with PeptiStrong on clinical responses in elderly adults with sarcopenia

Study Start Date: Sept. 10, 2025

Study Type: INTERVENTIONAL

Condition: Sarcopenia in Elderly Malnourished Protein Supplementation Muscle Mass Physical Function Strength

Intervention: OTHER: MediDrink Platinum+

MediDrink Platinum+ containing novel protein blend SPR-01

OTHER: MediDrink Platinum+ and PeptiStrong

MediDr...